Filter byLast updated dateSelectAfterBeforeFrom - ToDátumEnd DateThis weekThis monthLast weekLast monthCategoryHumanCorporateVeterinaryHerbalTopicMedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesCorporateEarly accessFeesProduct informationMedicines for use outside the EUMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurementDiseases areaViral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDSResponsible bodyCHMPCVMPPRACManagement BoardCOMPPDCOCMDhHMPCCATPatient safetyYesLeave this field blankFiltersResults (3754) Sort byLast update date (new to old)Last update date (old to new)A-ZZ-ALeave this field blankFifth Meeting of the EMEA Management Board took the form of the Official Inauguration 26 January 1995 NewsCorporateFourth Meeting of the Management Board of the European Agency for the Evaluation of Medical Products 28 October 1994 Press releaseCorporateThird Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products 23 June 1994 Press releaseCorporateSecond Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products 13 April 1994 Press releaseCorporatePrevious368369370371372373374375376
Fifth Meeting of the EMEA Management Board took the form of the Official Inauguration 26 January 1995 NewsCorporate
Fourth Meeting of the Management Board of the European Agency for the Evaluation of Medical Products 28 October 1994 Press releaseCorporate
Third Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products 23 June 1994 Press releaseCorporate
Second Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products 13 April 1994 Press releaseCorporate